Enhancement of Magnetic Hyperthermia by Mixing Synthetic Inorganic and Biomimetic Magnetic Nanoparticles
Metadatos
Mostrar el registro completo del ítemAutor
Iglesias Salto, Guillermo Ramón; Jabalera Ruz, Ylenia María; Peigneux, Ana; Checa Fernández, B. L.; Delgado Mora, Ángel Vicente; Jiménez López, ConcepciónEditorial
MDPI
Materia
Biomimetic magnetite Drug delivery Magnetic Hyperthermia Nanoparticles stability
Fecha
2019-06-11Referencia bibliográfica
Iglesias, G. R., Jabalera, Y., Peigneux, A., Fernández, C., Luna, B., Delgado, Á. V., & Jimenez-Lopez, C. (2019). Enhancement of Magnetic Hyperthermia by Mixing Synthetic Inorganic and Biomimetic Magnetic Nanoparticles. Pharmaceutics, 11(6), 273.
Patrocinador
We wish to thank FPU2016 grant (Ref. FPU16-04580), RYC-2014-6901 (MINECO, Spain), CGL2016-76723 (MINECO, Spain and FEDER, EU), Unidad Científica de Excelencia UCE-PP2016-05 (UGR) and Plan Propio Beca de iniciación a la investigación para estudiantes de master (UGR).Resumen
In this work we report on the synthesis and characterization of magnetic nanoparticles of
two distinct origins, one inorganic (MNPs) and the other biomimetic (BMNPs), the latter based on a
process of bacterial synthesis. Each of these two kinds of particles has its own advantages when used
separately with biomedical purposes. Thus, BMNPs present an isoelectric point below neutrality
(around pH 4.4), while MNPs show a zero-zeta potential at pH 7, and appear to be excellent agents for
magnetic hyperthermia. This means that the biomimetic particles are better suited to be loaded with
drug molecules positively charged at neutral pH (notably, doxorubicin, for instance) and releasing it
at the acidic tumor environment. In turn, MNPs may provide their transport capabilities under a
magnetic field. In this study it is proposed to use a mixture of both kinds of particles at two different
concentrations, trying to get the best from each of them. We study which mixture performs better from
different points of view, like stability and magnetic hyperthermia response, while keeping suitable
drug transport capabilities. This composite system is proposed as a close to ideal drug vehicle with
added enhanced hyperthermia response.